Bausch + Lomb Corporation ... to mitigate the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity to an aspheric ...

Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Shares of contact lens supplier Bausch + Lomb (BLCO) are surging in today’s trading amid news of a potential acquisition.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Eye health firm Bausch + Lomb has received marketing approval for its full range of enVista Envy vision intraocular lenses (IOL) from the US Food and Drug Administration (FDA). Following the ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) today and set a price target of $23.00. Yi Chen has given his Buy rating due to a ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Today’s best Samsung Galaxy Watch Ultra deal Samsung Galaxy Watch Ultra: was $649.99 now from $299.99 with a trade-in at Samsung The Samsung Galaxy Watch Ultra is almost in a league of its own ...

Bausch + Lomb Corporation (NYSE/TSX ... following removal of a cataractous lens to mitigate the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining ...

VAUGHAN, Ontario, October 14, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX ... of a cataractous lens to mitigate the effects of presbyopia by providing improved intermediate and ...

Bausch + Lomb is also in the process of seeking regulatory approvals ... corneal astigmatism following removal of a cataractous lens to mitigate the effects of presbyopia by providing improved ...